ICON (ICLR) Stock
Fundamentals
Source: third-party data provider, as of October 14, 2026
Compare with ICLR
Recent news

Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
ICLR

Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
ICLR

ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
ICLR

ICON Announces Private Offering of Notes
ICON Announces Private Offering of Notes
ICLR
Technical indicators
- RSI 14
- 47.39
- MACD 12/26/9
- -0.89
- EMA 9 of MACD
- -0.40
- MACD histogram
- -0.49
- SMA 50
- $166.73
- Price below SMA 50
- EMA 50
- $165.26
- Price below EMA 50
- SMA 200
- $145.90
- Price above SMA 200
- EMA 200
- $155.59
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 13, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
No data available
Debt & Balance Sheet
No data available
Revenue to Profit
No data available
Earnings
The market is expecting earnings per share of $3.17 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
ICLR

Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
ICLR

ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
ICLR

ICON Announces Private Offering of Notes
ICON Announces Private Offering of Notes
ICLR

ICON Announces Results of Annual General Meeting
ICON Announces Results of Annual General Meeting
ICLR

Icon Q2 Earnings Call Highlights
Icon Q2 Earnings Call Highlights
ICLR

Icon PLC (ICLR) Lags Q2 Earnings Estimates
Icon PLC (ICLR) Lags Q2 Earnings Estimates
ICLR

ICON Reports Second Quarter 2026 Results
ICON Reports Second Quarter 2026 Results
ICLR

ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials
ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials
ICLR

Icon PLC (ICLR) Up 5.8% Since Last Earnings Report: Can It Continue?
Icon PLC (ICLR) Up 5.8% Since Last Earnings Report: Can It Continue?
ICLR
About ICON
ICON is a Global Contract Research Organisation (CRO). We specialise in the strategic development, management and analysis of programs that support Clinical Development; from compound selection to Phase I-IV clinical studies. Our services can be implemented separately or as part of a comprehensive full service clinical programme that can help expedite the time it takes to bring a drug to market and monitor its performance and safety post approval.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Barry Balfe | CEO & Director | 1979 |
| Mr. Nigel Clerkin A.C.A. | Chief Financial Officer | 1974 |
| Dr. John Climax Ph.D. | Founder & Independent Non-Executive Director | 1953 |
| Mr. Steve Empoliti | Chief Commercial Officer | — |
| Lyons Emer | Chief Accounting Officer | — |
| Mr. Thomas N. O'Leary | Chief Information Officer | — |
| Mr. Diarmaid Cunningham | Chief Administrative Officer, General Counsel & Company Secretary | 1975 |
| Ms. Niamh Murphy | Director of Corporate Communications | — |
| Mr. David Green | Vice President of Marketing | — |
| Mr. Joe Cronin | Chief Human Resources Officer | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 14, 2026
Technical indicators
- RSI 14
- 47.39
- MACD 12/26/9
- -0.89
- EMA 9 of MACD
- -0.40
- MACD histogram
- -0.49
- SMA 50
- $166.73
- Price below SMA 50
- EMA 50
- $165.26
- Price below EMA 50
- SMA 200
- $145.90
- Price above SMA 200
- EMA 200
- $155.59
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 13, 2026. Technical data, not a recommendation.
Analyst views
4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $175.00
- Average
- $189.75
- High
- $209.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +4.3 | -6.4 | +13.5 | |||||||||
| 2022 | -10.2 | -11.3 | +5.2 | -8.3 | -2.1 | -0.9 | +13.4 | -11.3 | -11.9 | +4.6 | +9.7 | -11.2 |
| 2023 | +19.2 | -4.3 | -6.1 | -10.2 | +9.0 | +15.9 | +3.4 | +4.3 | -6.3 | +0.3 | +6.8 | +5.1 |
| 2024 | -7.1 | +23.1 | +3.2 | -10.2 | +7.7 | -3.1 | +3.8 | -1.6 | -8.0 | -21.9 | -4.6 | -1.8 |
| 2025 | -6.4 | -2.8 | -5.3 | -9.1 | -10.3 | +12.8 | +13.6 | +6.9 | -1.6 | -10.7 | +9.6 | +1.4 |
| 2026 | -4.5 | -39.4 | +2.2 | +6.2 | +20.6 | +25.8 | -6.6 | +4.2 | +5.3 | +1.5 |



